$3.570
-0.020 (-0.56%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PRME por análisis de gráficos similares
Alphio's PRME stock price prediction model matches the current Prime Medicine, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.48 (-2.66%). The 1-week path is $3.49 (-2.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Prime Medicine, Inc?
Prime Medicine Inc is a good buy right now due to its recent 6.49% increase over the last 5 days and a favorable RSI of 61.217, indicating bullish momentum. The positive arbitration ruling against Beam Therapeutics has removed a significant overhang, allowing the company to advance its PM647 treatment, which is expected to enter clinical trials soon. However, the main risk is the company's ongoing net losses, with a net income of -42,109,000 USD in Q2 2026, which highlights the financial challenges it faces as it seeks to commercialize its technology.
PRME cerró en $3.57 el Tuesday, tras bajar -0.56%
Prime Medicine, Inc (PRME) last closed at $3.57, losing -0.56%. These facts feed the 1-day and 1-week PRME price prediction above.
Factores de la previsión
Los factores de la previsión de Prime Medicine, Inc (PRME) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PRME, ordenadas por similitud.
Análisis de estacionalidad de PRME
Historically the probability of a positive September return for PRME is 52.38%. January offers the highest probability of a positive month at 52.46%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.